Laura Waters

603 total citations
13 papers, 101 citations indexed

About

Laura Waters is a scholar working on Molecular Biology, Infectious Diseases and Emergency Medicine. According to data from OpenAlex, Laura Waters has authored 13 papers receiving a total of 101 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Infectious Diseases and 3 papers in Emergency Medicine. Recurrent topics in Laura Waters's work include Cancer-related gene regulation (6 papers), HIV-related health complications and treatments (3 papers) and HIV/AIDS drug development and treatment (2 papers). Laura Waters is often cited by papers focused on Cancer-related gene regulation (6 papers), HIV-related health complications and treatments (3 papers) and HIV/AIDS drug development and treatment (2 papers). Laura Waters collaborates with scholars based in United Kingdom, United States and Japan. Laura Waters's co-authors include Mark Bower, M Nelson, B G Gazzard, Justin Stebbing, S Mandalia, Fiona C. Dempsey, Peter Maskell, Andrew Scourfield, James G. Christensen and Sundhiya Mandalia and has published in prestigious journals such as Cancer Research, Clinical Infectious Diseases and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Laura Waters

12 papers receiving 96 citations

Peers

Laura Waters

HEPAT

EPIDE

Jerry Cade United States

F.P. Antonucci Italy

Rafael Micán Spain

S. Chadapaud France

Víctor J. Moreno Cuerda Spain

Ana Martínez-Sapiña Spain

Bao-Chau Phung France

Sarah Henn United States

Maurizio Milesi Italy

Martine Robberechts Belgium

Jerry Cade United States

Laura Waters

28 ×0.6

HEPAT

58 ×1.7

EPIDE

10 ×0.4

11 ×0.5

48 ×2.2

Citations per year, relative to Laura Waters Laura Waters (= 1×) peers Jerry Cade

Countries citing papers authored by Laura Waters

Since Specialization

Citations

This map shows the geographic impact of Laura Waters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Waters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Waters more than expected).

Fields of papers citing papers by Laura Waters

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Waters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Waters. The network helps show where Laura Waters may publish in the future.

Co-authorship network of co-authors of Laura Waters

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Waters. A scholar is included among the top collaborators of Laura Waters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Waters. Laura Waters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Batterham, Rachel L., Roger Bedimo, Ricardo Sobhie Diaz, et al.. (2024). Cardiometabolic health in people with HIV: expert consensus review. Journal of Antimicrobial Chemotherapy. 79(6). 1218–1233. 7 indexed citations

Negrão, Marcelo V., David Molkentine, Laura D. Hover, et al.. (2024). Abstract 1212: Impact of KEAP1/STK11 co-mutations and NRF2 signaling on resistance to adagrasib in advanced NSCLC. Cancer Research. 84(6_Supplement). 1212–1212.

Waters, Laura, Ruth Aranda, Krystal Moya, et al.. (2024). Abstract 3319: The MTA-cooperative PRMT5 inhibitor, MRTX1719, demonstrates increased anti-tumor activity in combination with KRAS mutant-selective inhibitors in MTAP del,KRAS-mutant cancers. Cancer Research. 84(6_Supplement). 3319–3319. 2 indexed citations

Waters, Laura, Ruth Aranda, Krystal Moya, et al.. (2023). Abstract 2779: Identification of mechanism-based combination targets effective with the MTA-cooperative PRMT5 inhibitor MRTX1719 for the treatment of MTAP deleted cancers. Cancer Research. 83(7_Supplement). 2779–2779. 1 indexed citations

Aranda, Ruth, Laura Waters, Krystal Moya, et al.. (2023). Abstract 2778: A novel MTA-cooperative PRMT5 inhibitor, MRTX1719, stabilizes the ternary MTA-PRMT5 complex and leads to synthetic lethality in MTAP deleted cancers. Cancer Research. 83(7_Supplement). 2778–2778. 1 indexed citations

Smith, Christopher R., Ruth Aranda, James G. Christensen, et al.. (2022). Design and evaluation of achiral, non-atropisomeric 4-(aminomethyl)phthalazin-1(2H)-one derivatives as novel PRMT5/MTA inhibitors. Bioorganic & Medicinal Chemistry. 71. 116947–116947. 8 indexed citations

Smith, Christopher R., Svitlana Kulyk, Lars D. Engstrom, et al.. (2021). Abstract LB003: Fragment based discovery of MRTX9768, a synthetic lethal-based inhibitor designed to bind the PRMT5-MTA complex and selectively target MTAP/CDKN2A-deleted tumors. Cancer Research. 81(13_Supplement). LB003–LB003. 10 indexed citations

Smith, Christopher R., Lars D. Engstrom, Svitlana Kulyk, et al.. (2021). Abstract P165: MRTX1719: A first-in-class MTA-cooperative PRMT5 inhibitor that selectively elicits antitumor activity in MTAP/CDKN2A deleted cancer models. Molecular Cancer Therapeutics. 20(12_Supplement). P165–P165. 2 indexed citations

Engstrom, Lars D., Laura Waters, Sole Gatto, et al.. (2020). Abstract 5684: Drug-anchored in vitro and in vivo CRISPR screens to identify targetable vulnerabilities and modifiers of response to MRTX849 in KRASG12C-mutant models. Cancer Research. 80(16_Supplement). 5684–5684. 1 indexed citations

10.

Waters, Laura, et al.. (2018). The emergence of new psychoactive substance (NPS) benzodiazepines: A review. Drug Testing and Analysis. 10(2). 392–393. 15 indexed citations

11.

Ahmed, Nadia, et al.. (2014). Home delivery of medication – the role of a patient information leaflet on maximising service uptake. International Journal of STD & AIDS. 25(14). 1035–1037. 2 indexed citations

12.

Scourfield, Andrew, Laura Waters, Paul Holmes, et al.. (2011). Non-cirrhotic portal hypertension in HIV-infected individuals. International Journal of STD & AIDS. 22(6). 324–328. 20 indexed citations

13.

Stebbing, Justin, Laura Waters, S Mandalia, et al.. (2005). Hepatitis C Virus Infection in HIV Type 1--Infected Individuals Does Not Accelerate a Decrease in the CD4+ Cell Count but Does Increase the Likelihood of AIDS-Defining Events. Clinical Infectious Diseases. 41(6). 906–911. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact